Cost-effectiveness of end-game strategies against sleeping sickness across the Democratic Republic of Congo
PLOS Neglected Tropical Diseases · 22.10.2026 · 20 (10) · e0014777
DOI: 10.1371/journal.pntd.0014777 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 22.10.2026. Verfasst von Marina Antillon und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, Basel-Land, Switzerland. Hauptthemen laut MEDLINE: Trypanosomiasis, African, Cost-Benefit Analysis, Disease Eradication. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill & Melinda Gates Foundation, Bill and Melinda Gates Foundation, Belgian Directorate-general for Development Cooperation and Humanitarian Aid.
Abstract (Originalsprache)
Background
Gambiense human African trypanosomiasis (gHAT) is marked for elimination of transmission (EoT) by 2030. We examined the cost-effectiveness (CE) of EoT in the Democratic Republic of Congo, the country with the highest burden.
Methods
In 165 health zones (HZs), we modelled the transmission dynamics, health outcomes, and economic costs of six strategies during 2026–40, including cessation activities once reported cases reach zero. Uncertainty in CE was assessed within the net monetary framework, presenting optimal strategies across willingness-to-pay (WTP) values, in costs per disability-adjusted life-year averted. We assessed the optimal strategy for CE and EoT in each health zone separately, but present results by health zone, by coordination, and for the whole country.
Results
Status Quo strategies, CE strategies (WTP = $500), and strategies that maximise the probability of EoT by 2030 are predicted to yield EoT by 2030 in 118 HZs, 123 HZs, and 134 HZs respectively, at a cost by 2040 of $67.8M [95% PI: $36.7M–113M], $93.3M [95% PI: $51.6M–153M], $185M [95% PI: $111M–309M]. A more lenient timeline of EoT by 2040 would lead to EoT in 152 HZs at a cost of $158M [95% PI: $91.6-265M], leaving 13 HZs shy of the goal. Costs would have to be front-loaded; in 2026, while Status Quo strategies would cost $8.75M [95% PI: $7.01M–11.2M], elimination strategies would cost $27.0 [95% PI: $21.0M–35.2M]. Investing in EoT by 2030 is predicted to reduce 68% of gHAT deaths from 7979 [95% PI: 770–27,868] with Status Quo strategies to 2576 [95% PI: 255–9133].
Conclusions
Current tools could make considerable progress to maximise the probability of EoT by 2030, but novel tools could help in select health zones that are facing a low probability of EoT even with more ambitious strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, Basel-Land, Switzerland.
- University of Basel, Basel-Stadt, Switzerland.
- Zeeman Institute, University of Warwick, Coventry, United Kingdom.
- Mathematics Institute, University of Warwick, Coventry, United Kingdom.
- Warwick Medical School, University of Warwick, Coventry, United Kingdom.
- Warwick Centre for Global Health, University of Warwick, Coventry, United Kingdom.
ORCID-Profile: Marina Antillon
Förderung
- Bill & Melinda Gates Foundation
- Bill and Melinda Gates Foundation
- Belgian Directorate-general for Development Cooperation and Humanitarian Aid
Zitieren
APA
Antillon, M., Huang, C. I., Sutherland, S. A., Crump, R. E., Brown, P. E., Bessell, P. R., Crowley, E. H., Snijders, R., Hope, A., Tirados, I., Dunkley, S., Verlé, P., Lebuki, J., Shampa, C., Miaka, E. M., Tediosi, F., & Rock, K. S. (2026). Cost-effectiveness of end-game strategies against sleeping sickness across the Democratic Republic of Congo. PLOS Neglected Tropical Diseases, 20(10), e0014777. https://doi.org/10.1371/journal.pntd.0014777
Vancouver
Antillon M, Huang CI, Sutherland SA, Crump RE, Brown PE, Bessell PR, et al. Cost-effectiveness of end-game strategies against sleeping sickness across the Democratic Republic of Congo. PLOS Neglected Tropical Diseases. 2026;20(10):e0014777. doi:10.1371/journal.pntd.0014777
BibTeX
@article{Antillon2026,
author = {Antillon, Marina and Huang, Ching-I and Sutherland, Samuel A and Crump, Ronald E and Brown, Paul E and Bessell, Paul R and Crowley, Emily H and Snijders, Rian and Hope, Andrew and Tirados, Iñaki and Dunkley, Sophie and Verlé, Paul and Lebuki, Junior and Shampa, Chansy and Miaka, Erick Mwamba and Tediosi, Fabrizio and Rock, Kat S},
title = {Cost-effectiveness of end-game strategies against sleeping sickness across the Democratic Republic of Congo},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
volume = {20},
number = {10},
pages = {e0014777},
doi = {10.1371/journal.pntd.0014777}
}
EUVIMED